Mereo BioPharma Group PLC (MREO)
3.50
-0.25
(-6.67%)
USD |
NASDAQ |
Jun 25, 16:00
3.62
+0.12
(+3.43%)
Pre-Market: 20:00
Mereo BioPharma Group Cash from Investing (Quarterly): -0.70M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.70M |
| June 30, 2023 | 0.5842M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.419M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.70M
Minimum
Mar 2024
0.5842M
Maximum
Jun 2023
-0.1783M
Average
-0.419M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -0.358M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0545M |
| Verona Pharma PLC | -0.016M |
| Autolus Therapeutics PLC | -0.533M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.991M |
| Free Cash Flow Per Share (Quarterly) | -0.0621 |